Differences in viral and host genetic risk factors for development of human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis between Iranian and Japanese HTLV-1-infected individuals

Journal of General Virology

Volumn 86, Issue 3, 2005, Pages 773-781

  Sabouri, Amir H ^a   Saito, Mineki ^a   Usuku, Koichiro ^a   Bajestan, Sepideh Naghibzadeh ^a   Mahmoudi, Mahmoud ^b   Forughipour, Mohsen ^c   Sabouri, Zahra ^b   Abbaspour, Zahra ^b   Goharjoo, Mohammad ^c   Khayami, Esmaeil ^d   Hasani, Ali ^d   Izumo, Shuji ^e   Arimura, Kimiyoshi ^a   Farid, Reza ^b   Osame, Mitsuhiro ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d Khorasan Blood Transfusion Center   (Iran)

^e KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A2 ANTIGEN; HLA C ANTIGEN; HLA DR ANTIGEN; TAX PROTEIN;

ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENDEMIC DISEASE; GENE SEQUENCE; GENETIC RISK; HLA SYSTEM; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; INFECTION PREVENTION; IRAN; JAPAN; NONHUMAN; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROVIRUS; RISK ASSESSMENT; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; VIRUS CELL INTERACTION; VIRUS LOAD;

GENETIC PREDISPOSITION TO DISEASE; HLA-A ANTIGENS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; IRAN; JAPAN; PARAPARESIS, TROPICAL SPASTIC; RISK FACTORS;

HTLV; HUMAN T-LYMPHOTROPIC VIRUS 1; IRANIA; SUBGROUP A; SUBGROUP B;

EID: 20044388112     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.80509-0     Document Type: Article

References (38)

1. Abbaszadegan, M. R., Gholamin, M., Tabatabaee, A., Farid, R., Houshmand, M. & Abbaszadegan, M. (2003). Prevalence of human T-lymphotropic virus type 1 among blood donors from Mashhad, Iran. J Clin Microbiol 41, 2593-2595.
2. Apple, R. J., Erlich, H. A., Klitz, W., Manos, M. M., Becker, T. M. & Wheeler, C. M. (1994). HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nat Genet 6, 157-162.
3. Arakaki, T., Kohakura, M., Asato, R., Ikeshiro, T., Nakamura, S. & Iwanaga, M. (1992). Epidemiological aspects of Strongyloides stercoralis infection in Okinawa, Japan. J Trop Med Hyg 95, 210-213.
4. Bangham, C. R. (2000). The immune response to HTLV-1. Curr Opin Immunol 12, 397-402.
5. Biggar, R. J., Saxinger, C., Gardiner, C., Collins, W. E., Levine, P. H., Clark, J. W., Nkrumah, F. K. & Blattner, W. A. (1984 . Type-I HTLV antibody in urban and rural Ghana, West Africa. Int J Cancer 34, 215-219.
6. Blattner, W. A., Kalyanaraman, V. S., Robert-Guroff, M. & 7 other authors (1982). The human type-C retrovirus, HTLV, in Blacks from the Caribbean region, and relationship to adult T-cell leukemia/lymphoma. Int J Cancer 30, 257-264.
7. Bunce, M., O'Neill, C. M., Barnardo, M. C., Krausa, P., Browning, M. J., Morris, P. J. & Welsh, K. I. (1995). Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 46, 355-367.
8. Cartier, L., Araya, F., Castillo, J. L. & 8 other authors (1993). Southernmost carriers of HTLV-I/II in the world. Jpn J Cancer Res 84, 1-3.
9. Furukawa, Y., Yamashita, M., Usuku, K., Izumo, S., Nakagawa, M. & Osame, M. (2000). Phylogenetic subgroups of human T cell lymphotropic virus (HTLV) type I in the tax gene and their association with different risks for HTLV-1-associated myelopathy/tropical spastic paraparesis. J Infect Dis 182, 1343-1349.
10. Gabet, A. S., Mortreux, F., Talarmin, A. & 7 other authors (2000). High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasis. Oncogene 19, 4954-4960.
11. Gessain, A., Barin, F., Vernant, J. C., Gout, O., Maurs, L., Calender, A. & de The, G. (1985). Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet ii, 407-410.
12. Hill, A. V. (1998). The immunogenetics of human infectious diseases. Annu Rev Immunol 16, 593-617.
13. Hinuma, Y., Nagata, K., Hanaoka, M., Nakai, M., Matsumoto, T., Kinoshita, K. I., Shirakawa, S. & Miyoshi, I. (1981). Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci U S A 78, 6476-6480.
14. Ijichi, S., Izumo, S., Eiraku, N. & 8 other authors (1993). An autoaggressive process against bystander tissues in HTLV-1-infected individuals: a possible pathomechanism of HAM/TSP. Med Hypotheses 41, 542-547.
15. Jeffery, K. J., Usuku, K., Hall, S. E. & 14 other authors (1999). HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-1-associated myelopathy. Proc Natl Acad Sci U S A 96, 3848-3853.
16. Jeffery, K. J., Siddiqui, A. A., Bunce, M. & 8 other authors (2000). The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. J Immunol 165, 7278-7284.
17. Kaplan, J. E., Osame, M., Kubota, H., Igata, A., Nishitani, H., Maeda, Y., Khabbaz, R. F. & Janssen, R. S. (1990 . The risk of development of HTLV-1-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-1. J Acquir Immune Defic Syndr 3, 1096-1101.
18. Kaplan, J. E., Khabbaz, R. F., Murphy, E. L. & 12 other authors (1996). Male-to-female transmission of human T-cell lymphotropic virus types I and II: association with viral load. The Retrovirus Epidemiology Donor Study Group. J Acquir Immune Defic Syndr Hum Retrovirol 12, 193-201.
19. + T lymphocytes recognize a highly conserved epitope of human T lymphotropic virus type 1 (HTLV-1) env gp21 restricted by HLA DRB1*0101. Clin Exp Immunol 111, 278-285.
20. Miura, T., Fukunaga, T., Igarashi, T. & 7 other authors (1994). Phylogenetic subtypes of human T-lymphotropic virus type I and their relations to the anthropological background. Proc Natl Acad Sci U S A 91, 1124-1127.
21. + T lymphocytes. Ann Neurol 40, 84-90.
22. Nagai, M., Usuku, K., Matsumoto, W. & 8 other authors (1998). Analysis of HTLV-1 proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-1 carriers: high proviral load strongly pre-disposes to HAM/TSP. J Neurovirol 4, 586-593.
23. Olerup, O. & Zetterquist, H. (1992). HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 39, 225-235.
24. Osame, M. (1990). Review of WHO Kagoshima meeting and diagnostic guidelines for HAM/TSP. In Human Retrovirology: HTLV, pp. 191-197. Edited by W. A. Blattner. New York: Raven Press.
25. Osame, M., Usuku, K., Izumo, S., Ijichi, N., Amitani, H., Igata, A., Matsumoto, M. & Tara, M. (1986). HTLV-1 associated myelopathy, a new clinical entity. Lancet i, 1031-1032.
26. Poiesz, B. J., Ruscetti, F. W., Gazdar, A. F., Bunn, P. A., Minna, J. D. & Gallo, R. C. (1980). Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A 77, 7415-7419.
27. Safai, B., Huang, J. L., Boeri, E., Farid, R., Raafat, J., Schutzer, P., Ahkami, R. & Franchini, G. (1996). Prevalence of HTLV type I infection in Iran: a serological and genetic study. AIDS Res Hum Retroviruses 12, 1185-1190.
28. Seiki, M., Hattori, S., Hirayama, Y. & Yoshida, M. (1983). Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc Natl Acad Sci U S A 80, 3618-3622.
29. Takenouchi, N., Yamano, Y., Usuku, K., Osame, M. & Izumo, S. (2003). Usefulness of proviral load measurement for monitoring of disease activity in individual patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis. J Neurovirol 9, 29-35.
30. Umehara, F., Izumo, S., Nakagawa, M., Ronquillo, A. T., Takahashi, K., Matsumuro, K., Sato, E. & Osame, M. (1993). Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-1-associated myelopathy. J Neuropathol Exp Neurol 52, 424-430.
31. Woolf, B. (1955). On estimating the relationship between blood group and disease. Ann Hum Genet 19, 251-253.
32. Yamano, Y., Kitze, B., Yashiki, S. & 7 other authors (1997). Preferential recognition of synthetic peptides from HTLV-1 gp21 envelope protein by HLA-DRB1 alleles associated with HAM/TSP (HTLV-1-associated myelopathy/tropical spastic paraparesis). J Neuroimmunol 76, 50-60.
33. Yamashita, M., Achiron, A., Miura, T. & 7 other authors (1995). HTLV-I from Iranian Mashhadi Jews in Israel is phylogenetically related to that of Japan, India, and South America rather than to that of Africa and Melanesia. Virus Genes 10, 85-90.
34. Yanagihara, R., Jenkins, C. L., Alexander, S. S., Mora, C. A. & Garruto, R. M. (1990). Human T lymphotropic virus type I infection in Papua New Guinea: high prevalence among the Hagahai confirmed by western analysis. J Infect Dis 162, 649-654.
35. Yoshida, M., Miyoshi, I. & Hinuma, Y. (1982). Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci U S A 79, 2031-2035.
36. Yoshida, M., Seiki, M., Yamaguchi, K. & Takatsuki, K. (1984). Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci U S A 81, 2534-2537.
37. Zamora, T., Zaninovic, V., Kajiwara, M., Komoda, H., Hayami, M. & Tajima, K. (1990). Antibody to HTLV-1 in indigenous inhabitants of the Andes and Amazon regions in Colombia. Jpn J Cancer Res 81, 715-719.
38. Zaninovic, V., Sanzon, F., Lopez, F. & 9 other authors (1994). Geographic independence of HTLV-I and HTLV-II foci in the Andes highland, the Atlantic coast, and the Orinoco of Colombia. AIDS Res Hum Retroviruses 10, 97-101.